Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$229K Sell
1,782
-402
-18% -$47.1K 0.03% 133
2026
Q1
$263K Buy
+2,184
New +$252K 0.04% 121
2024
Q3
Sell
-1,629
Closed -$202K 98
2024
Q2
$202K Sell
1,629
-130
-7% -$16.7K 0.05% 92
2024
Q1
$232K Buy
+1,759
New +$217K 0.06% 80

Other funds holding MRK

Burton Enright Welch's MRK Position: Q2 2026 in Review

Burton Enright Welch reduced its Merck (MRK) stake by 18% in Q2 2026, selling an estimated $47.1K and leaving 1,782 shares worth $229K. The position accounts for 0.03% of the portfolio, ranked #133.

Burton Enright Welch first reported a position in MRK in Q1 2024 and has held it in 4 quarters since. The position peaked at $263K in Q1 2026. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Burton Enright Welch held 1,782 shares of Merck worth $229K as of Q2 2026.
  • Burton Enright Welch sold 402 Merck shares in Q2 2026, an estimated $47.1K.
  • Merck made up 0.03% of Burton Enright Welch's portfolio in Q2 2026, its #133 holding.
  • Burton Enright Welch first reported a position in Merck in Q1 2024 and has held it in 4 quarters since.
  • Burton Enright Welch's Merck position peaked at $263K in Q1 2026.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Burton Enright Welch's 13F filing for Q2 2026, filed 17 Jul 2026.